This study was undertaken to identify and evaluate the waste
reduction management strategies in Glaxo Simithline (GSK) Nigeria Plc, Lagos.
In generating total need to achieve the objective of
the study, the researcher consulted many textbook, journals, periodicals and
paper work. These were renewed and deductions and additions were made
appropriately. The study was also conducted by using primary and secondary
sources of data collection as well as percentage and made in the data analysis
and interpretation. Based on the analysis of data some findings include
that good waste reduction management strategies exist and these include but not
limited to processes improvement strategies emphasis on efficiency maintenance
of plants/equipment and employing qualified trained personnel. Therefore,
this work suggest that the company should intensify, efforts towards achieving
zero waste through establishment of secondary application for all waster
1.1 Background of the study
1.2 Statement of the problem
1.3 Objective of the study
1.4 Research Question
1.5 Research Hypothesis
1.6 Significance of the Study
1.7 Scope of the Study
1.8 Limitation of the study
1.9 Definition of terms
2.1 Literature of Related Review
2.2 Waste Prevention Models
2.3 Waste Disposal Techniques
2.4 Waste minimization strategies
2.5 Case studies on Waste Minimization
2.6 Basel convention on Waste Management
2.7 Overview of facility- Glaxo smithline
2.8 Existing Waste Management strategies by
3.1 Source of Data
3.2 Study Population
3.3 Sampling size Determination
3.5 Data Collection Instrument
3.6 Method of Data Analysis
3.7 Decision Rule
3.8 Validity and Reliability of
4.0 Data Presentation and Analysis
4.1 Presentation and Analysis of
4.3 Summary of
Summary of Findings, Conclusion and Recommendation
5.1 Summary of Findings
1.1 BACKGROUND OF THE STUDY
Glaxo Smithkline (GSK) Nigeria Plc, is a corporate organization,
which was incorporated in Nigeria as a public limited liability company in
1971. Currently it has tow factories located in Agbara and Ilupeju, GS is
quoted on the Nigeria stock market and is positioned to be the leading
pharmaceutical company in Nigeria GS line of product include
Panadol, Panadol Extra, Cotenol, Phensix and Phensicplus.
drinks: Lucozads, lucozade boest etc
Andrews liver salt.
The analgesics, multivitamin tonic and laxatives are manufactured
at the Ilupeju factory, while the Agbara orsal care is under contract
manufacture with UACP and PP as an embodiment of it’s valves GS integrates
environment and safety into the very fabric of the business to benefit her
various customers and to achieve:
- Compliance with all applicable laws, regulations
legislation and GS environment and safety standards
- A work culture that promotes a safe work place
characterized by absence of occupation injures and illnesses.
- Safe and environmentally responsible development
and manufacture of her products.
- Protection of the environment through the
optimal utilization of resources and prevention of any adverse impact on the
environment and the global community.
- Worldwide leadership in the industry with a
superior environment and safety vision: the foundation of a environment and
safety programmes is set out in policy statement, which commits GS to
- Improve efficiency and reduce waste
- Maximize the efficient use of energy.
- Design packaging to minimize resources uses and
maximize recycling capabilities.
- Operate responsibility and cooperatively with
the community (Hagan, 2000).
There also, exist standards, covering emissions to air and water,
waste disposal and energy usage in GSK Nigeria Plc generally, there exist
- Identification and classification of waste
- Waste generation rates
- Segregation and storage of waste
- Identification and selection of waste recycling,
recovery storage and disposal options
- Transportation of waste
- Waste disposal contractor management
- Documentation and record keeping
- Management of waste produced by contractors
working for GSk
All manufacturing process are usually accomplained with by waste
generation. In GSK sources of waste include the various raw and packaging
materials, chemical and chemical products, intermediate and finished
products, metal scraps, sand, spent grease oil, gaseous emissions/fumes
petrochemical and domestic wastes.
These waste are
commonly categorized into three forms viz solid waste, liquid/effluent waste,
and sem-solid (paste form) waste.
These forms of waste could be hazardous or non-hazardous. The
hazardous waste include:
solvents – eg tablets/powers/liquid/or pastes destroyed by soaking and diluting
with water, manufacturing floor washings, mopped up spill etc
- All waste laboratory chemicals-resulting from
analysis expired chemical etc
- Use of asbestos and metals (equipment
The non-hazardous waste include but not limited in packaging waste
paper, plastic, food.
including strategies has been a global concern and its effect on
environment is currently top on international agenda. To this effect GSK budget
and spends an average of N2.5 million on waste management annually.
1.2 STATEMENT OF THE PROBLEM
Waste is an inevitable problem, and penalty is paid by
industrialized and industrializing nations. Effort have been geared
towards the treatment, disposal and management of waste with the driving
objective of improving current health and environmental impacts.
A most promising step in solving various waste problems is
the prevention of waste at it’s source.
Pharmaceutical industries have been identified as one of the major
culprist in the issue of waste mismanagement. This is considering the kind of
hazardous and non-hazardous substances produced from their activities and which
have also led to serious problems to both the industry and society at large,
like economic financial loss, pollution/epidemic and even death. It is
important to access how these problems arise.
1.3 OBJECTIVE OF THE STUDY
Various waste reduction strategies have been adapted by different
communities/organizations in the economy but now effective these strategies
have been over the years shall be major focus of this study. In this, with
this, the study objectives of this work will include:
ascertain the extent to which firms plan and disposal of their wastes.
critically appraise the methods of waste disposal in Galxo Smithklin Nigeria
highlight the likely consequences of poor waste management in GSK in
particular, and the nation at large.
ascertain the organizational variable that will make for effective waste
highlight the potential benefits of effective waste management in GSK.
add to the existing knowledge in the field so as to assist in further research.
1.4 RESEARCH QUESTION
firms actively plan and engage in waste disposal and management?
poor waste management a major cause of firms – mortality in the pharmaceutical
waste reduction part of the social responsibility of the company?
the waste management strategies Glaxo Smithkline pharmaceutical industry
other ways could the company use for effective management of waste in the
1.5 RESEARCH HYPOTHESIS
Industries do not deliberately plan for waste disposal and management.
Adequate was disposal and management is a major planning decision in the
There is no significant relationship between firms morality in the
pharmaceutical industry and their waste management programs.
Companies social responsibilities, to not include the issue of waste disposal
Companies social responsibilities include effective waste management attract
positive relationship with the firm and public.
OF THE STUDY
This research work has been carried out to serve as a source
material for the management of waste in the waste management industry in
particular and the economy as a whole.
Indepth study has done on area like:
- Identifying ways of optimizing existing processes
- Minimizing emissions and therefore pollution
control and abatement costs
- Company’s image and goodwill, etc
The practical exposure and operations of firms in the industry,
vis-à-vis the enormous problems of waste management which this exercise has
given to the researcher is quite appreciated and of future benefit.
Finally, there is no doubt that other researchers in this
field and Glaxo Smithkline Plc in particular, will find this work interesting,
useful and quite challenging.
1.7 SCOPE OF THE STUDY
For the purpose of this study, the scope shall be limited to the
waste generation, treatment and disposal with special interest on waste
reduction strategies adopted within Glaxo Smithline Nigeria Plc (Ojota and its
factories) over the past decade during the period under study (early 90’s –
2003). It is possible that some required data may not have been properly
documented but efforts should be made to historically generate such data, which
will be subjected to valid statistically engineered historical data is subject
1.8 DEFINITION OF TERMS
Discarded substance that can no longer be used, and which has no apparent
commercial cycle: Refers to the interest in the management of waste materials
inevarchy: Pyramid of waste treatment options that offer the best available
option in a descending order.
principle: Waste disposal to sent to the facility nearest to the site of
TERMS AND CONDITIONS APPLY
For more informations on project materials and more